DK3490535T3 - Depotsammensætning, der omfatter mikroniseret tolcapon - Google Patents
Depotsammensætning, der omfatter mikroniseret tolcapon Download PDFInfo
- Publication number
- DK3490535T3 DK3490535T3 DK17743358.8T DK17743358T DK3490535T3 DK 3490535 T3 DK3490535 T3 DK 3490535T3 DK 17743358 T DK17743358 T DK 17743358T DK 3490535 T3 DK3490535 T3 DK 3490535T3
- Authority
- DK
- Denmark
- Prior art keywords
- tolcapon
- composition including
- deposit composition
- including micronized
- micronized
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16382372.7A EP3275433A1 (en) | 2016-07-29 | 2016-07-29 | Sustained release composition comprising micronized tolcapone |
| PCT/EP2017/069168 WO2018019997A1 (en) | 2016-07-29 | 2017-07-28 | Sustained release composition comprising micronized tolcapone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3490535T3 true DK3490535T3 (da) | 2021-10-04 |
Family
ID=56571284
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17743358.8T DK3490535T3 (da) | 2016-07-29 | 2017-07-28 | Depotsammensætning, der omfatter mikroniseret tolcapon |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11883538B2 (OSRAM) |
| EP (2) | EP3275433A1 (OSRAM) |
| JP (1) | JP7047236B2 (OSRAM) |
| KR (1) | KR102484678B1 (OSRAM) |
| CN (1) | CN109789100A (OSRAM) |
| AU (1) | AU2017303333B2 (OSRAM) |
| DK (1) | DK3490535T3 (OSRAM) |
| ES (1) | ES2891355T3 (OSRAM) |
| MX (1) | MX391116B (OSRAM) |
| PT (1) | PT3490535T (OSRAM) |
| RU (1) | RU2750670C2 (OSRAM) |
| WO (1) | WO2018019997A1 (OSRAM) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025536853A (ja) * | 2022-10-10 | 2025-11-07 | コリノ セラピューティクス，インク． | 放出調節トルカポン処方剤 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5236952A (en) | 1986-03-11 | 1993-08-17 | Hoffmann-La Roche Inc. | Catechol derivatives |
| DE69733752T2 (de) | 1996-05-20 | 2006-06-01 | G.D. Searle Llc, Chicago | Arzneimittel enthaltend oxaprozin-natriumsalz,-kaliumsalz, oder-tris(hydroxymethyl)aminomethansalz |
| AU3705799A (en) | 1998-04-09 | 1999-11-01 | F. Hoffmann-La Roche Ag | Process for the manufacture of (sub)micron sized particles by dissolving in compressed gas and surfactants |
| US6599530B2 (en) * | 1998-09-14 | 2003-07-29 | Orion Corporation | Oral compacted composition comprising catechol derivatives |
| GB2348371B (en) * | 2000-03-14 | 2001-04-04 | Soares Da Silva Patricio | Compositions comprising blockers of L-DOPA renal cell transfer for the treatment of Parkinson's disease |
| US9492388B2 (en) * | 2002-12-20 | 2016-11-15 | St. James Associates Llc/Faber Research Series | Coated particles for sustained-release pharmaceutical administration |
| CA2611114C (en) * | 2005-06-08 | 2014-09-23 | Orion Corporation | An entacapone-containing oral dosage form |
| CA2673485A1 (en) * | 2007-01-15 | 2008-07-24 | Kissei Pharmaceutical Co., Ltd. | Gastric retention-type sustained-release levodopa preparation |
| PL2640358T3 (pl) * | 2010-11-15 | 2018-06-29 | Neuroderm Ltd | Ciągłe podawanie l-dopy, inhibitorów dopa-dekarboksylazy, inhibitorów katecholo-o-metylotransferazy i ich kompozycji |
| CN103415513B (zh) | 2011-03-14 | 2016-01-20 | 勃林格殷格翰国际有限公司 | 白三烯产物的苯并二氧杂环己烷抑制剂 |
| CN103889407B (zh) * | 2011-10-24 | 2017-03-15 | 索姆创新生物技术公司 | 用于甲状腺素运载蛋白相关的淀粉样变性的疗法 |
| US20130195973A1 (en) * | 2012-01-30 | 2013-08-01 | Ranbaxy Laboratories Limited | Extended release pharmaceutical dosage forms of carbidopa and levodopa and process of preparation thereof |
| BR112015022390A8 (pt) * | 2013-03-13 | 2019-11-26 | Neuroderm Ltd | uso de carbidopa, levodopa e um inibidor de comt para a preparação de uma composição para tratamento de doença de parkinson |
| KR102457026B1 (ko) * | 2013-11-05 | 2022-10-21 | 신애질 코포레이션 | 입을 통한 연속적 약물 전달 |
| WO2016036308A1 (en) * | 2014-09-04 | 2016-03-10 | Lobsor Pharmaceuticals Aktiebolag | Pharmaceutical compositions comprising levodopa, a dopamine decarboxylase inhibitor and a comt inhibitor and method of administration thereof |
-
2016
- 2016-07-29 EP EP16382372.7A patent/EP3275433A1/en not_active Withdrawn
-
2017
- 2017-07-28 RU RU2019103647A patent/RU2750670C2/ru active
- 2017-07-28 CN CN201780060604.7A patent/CN109789100A/zh active Pending
- 2017-07-28 US US16/321,336 patent/US11883538B2/en active Active
- 2017-07-28 DK DK17743358.8T patent/DK3490535T3/da active
- 2017-07-28 AU AU2017303333A patent/AU2017303333B2/en active Active
- 2017-07-28 PT PT177433588T patent/PT3490535T/pt unknown
- 2017-07-28 WO PCT/EP2017/069168 patent/WO2018019997A1/en not_active Ceased
- 2017-07-28 KR KR1020197004664A patent/KR102484678B1/ko active Active
- 2017-07-28 JP JP2019526375A patent/JP7047236B2/ja active Active
- 2017-07-28 MX MX2019001190A patent/MX391116B/es unknown
- 2017-07-28 EP EP17743358.8A patent/EP3490535B1/en active Active
- 2017-07-28 ES ES17743358T patent/ES2891355T3/es active Active
-
2024
- 2024-01-29 US US18/425,739 patent/US12220487B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2750670C2 (ru) | 2021-06-30 |
| MX2019001190A (es) | 2019-09-06 |
| MX391116B (es) | 2025-03-21 |
| BR112019001826A2 (pt) | 2019-05-07 |
| KR102484678B1 (ko) | 2023-01-03 |
| WO2018019997A1 (en) | 2018-02-01 |
| PT3490535T (pt) | 2021-09-30 |
| RU2019103647A3 (OSRAM) | 2020-10-12 |
| EP3490535A1 (en) | 2019-06-05 |
| AU2017303333A1 (en) | 2019-03-14 |
| EP3490535B1 (en) | 2021-07-14 |
| RU2019103647A (ru) | 2020-08-28 |
| JP2019523305A (ja) | 2019-08-22 |
| AU2017303333B2 (en) | 2023-03-30 |
| US12220487B2 (en) | 2025-02-11 |
| ES2891355T3 (es) | 2022-01-27 |
| CN109789100A (zh) | 2019-05-21 |
| US20190167596A1 (en) | 2019-06-06 |
| US20240216282A1 (en) | 2024-07-04 |
| KR20190034563A (ko) | 2019-04-02 |
| JP7047236B2 (ja) | 2022-04-05 |
| CA3032211A1 (en) | 2018-02-01 |
| US11883538B2 (en) | 2024-01-30 |
| EP3275433A1 (en) | 2018-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3722358A4 (en) | COMPOSITION | |
| DK3697376T3 (da) | Sammensætning | |
| EP3534968A4 (en) | ANTI-BCMA T CAR LYMPHOCYTE COMPOSITIONS | |
| EP3493800A4 (en) | CANNABIS | |
| LT3240415T (lt) | Fungicidinės kompozicijos | |
| BR112016023628A2 (pt) | composições farmacêuticas. | |
| DK3416996T3 (da) | Hærdelig sammensætning | |
| EP3339331A4 (en) | COMPOSITION | |
| EP3398996A4 (en) | COMPOSITION | |
| BR112017001922A2 (pt) | composições fungicidas | |
| DK3250182T3 (da) | Dispergible sammensætninger | |
| DK3334726T3 (da) | Plinabulinsammensætninger | |
| DK3319597T3 (da) | Sammensætninger, der omfatter antistof-duocarmycin-lægemiddelkonjugater | |
| DK3528902T3 (da) | Ringegelsammensætning | |
| EP3395887C0 (en) | FLUOROR RUBBER COMPOSITION | |
| EP3480228A4 (en) | COMPOSITION | |
| DK3322295T3 (da) | Sammensætning | |
| DK3331498T3 (da) | Nasalsammensætning | |
| DK3316857T3 (da) | Multifasiske sammensætninger | |
| DK3389633T3 (da) | Farmaceutiske sammensætninger, der omfatter phenylaminopyrimidinderivat | |
| EP3556804A4 (en) | COMPOSITION | |
| DK3528791T3 (da) | Dispergible sammensætninger | |
| DK3393254T3 (da) | Sammensætning | |
| LT3173071T (lt) | Maropitanto kompozicija | |
| EP3369418A4 (en) | COMPOSITION |